Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.240
-0.030 (-2.36%)
May 14, 2025, 9:56 AM - Market open
Autolus Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 9.01 | 10.12 | 1.7 | 6.36 | 2.33 | 1.72 | Upgrade
|
| Revenue | 9.01 | 10.12 | 1.7 | 6.36 | 2.33 | 1.72 | Upgrade
|
| Revenue Growth (YoY) | -14.16% | 496.00% | -73.30% | 172.96% | 35.86% | -41.02% | Upgrade
|
| Cost of Revenue | 158.97 | 141.02 | 122.31 | 117.35 | 110.84 | 134.89 | Upgrade
|
| Gross Profit | -149.96 | -130.9 | -120.62 | -110.99 | -108.51 | -133.17 | Upgrade
|
| Selling, General & Admin | 121.25 | 109.89 | 54.91 | 31.9 | 31.87 | 34.97 | Upgrade
|
| Research & Development | -3.94 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 117.31 | 109.89 | 54.91 | 31.9 | 31.87 | 34.97 | Upgrade
|
| Operating Income | -267.27 | -240.79 | -175.53 | -142.89 | -140.37 | -168.15 | Upgrade
|
| Interest Expense | -9.29 | -9.29 | -45.07 | -8.91 | -1.11 | - | Upgrade
|
| Interest & Investment Income | 32.36 | 32.36 | 13.51 | 1.71 | 0.26 | 0.54 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.99 | -0.99 | 2.64 | 1.8 | -2.3 | -0.2 | Upgrade
|
| Other Non Operating Income (Expenses) | 11.57 | 0.32 | 0.22 | 0.34 | 0.16 | 1.55 | Upgrade
|
| EBT Excluding Unusual Items | -233.63 | -218.4 | -204.23 | -147.95 | -143.36 | -166.26 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.23 | -0.22 | -3.79 | -0.52 | -0.68 | - | Upgrade
|
| Asset Writedown | -0.41 | -0.41 | -0.38 | - | - | - | Upgrade
|
| Other Unusual Items | -0.1 | -0.1 | - | -0.1 | 2 | - | Upgrade
|
| Pretax Income | -234.37 | -219.13 | -208.4 | -148.57 | -142.04 | -166.26 | Upgrade
|
| Income Tax Expense | 3.76 | 1.53 | -0.02 | 0.27 | 0.06 | -24.16 | Upgrade
|
| Net Income | -238.13 | -220.66 | -208.38 | -148.84 | -142.1 | -142.09 | Upgrade
|
| Net Income to Common | -238.13 | -220.66 | -208.38 | -148.84 | -142.1 | -142.09 | Upgrade
|
| Shares Outstanding (Basic) | 266 | 255 | 174 | 95 | 72 | 52 | Upgrade
|
| Shares Outstanding (Diluted) | 266 | 255 | 174 | 95 | 72 | 52 | Upgrade
|
| Shares Change (YoY) | 43.07% | 46.69% | 83.11% | 31.78% | 39.81% | 19.72% | Upgrade
|
| EPS (Basic) | -0.89 | -0.86 | -1.20 | -1.57 | -1.97 | -2.76 | Upgrade
|
| EPS (Diluted) | -0.89 | -0.86 | -1.20 | -1.57 | -1.97 | -2.76 | Upgrade
|
| Free Cash Flow | - | -228.35 | -156.57 | -123.15 | -126.72 | -132.44 | Upgrade
|
| Free Cash Flow Per Share | - | -0.90 | -0.90 | -1.30 | -1.76 | -2.57 | Upgrade
|
| Operating Margin | -2966.03% | -2379.34% | -10337.34% | -2246.74% | -6024.64% | -9804.37% | Upgrade
|
| Profit Margin | -2642.69% | -2180.45% | -12272.26% | -2340.24% | -6098.54% | -8285.36% | Upgrade
|
| Free Cash Flow Margin | - | -2256.38% | -9221.02% | -1936.31% | -5438.54% | -7722.39% | Upgrade
|
| EBITDA | -259.43 | -233.07 | -168.96 | -135.54 | -132.01 | -162.58 | Upgrade
|
| D&A For EBITDA | 7.84 | 7.72 | 6.57 | 7.36 | 8.37 | 5.57 | Upgrade
|
| EBIT | -267.27 | -240.79 | -175.53 | -142.89 | -140.37 | -168.15 | Upgrade
|
| Revenue as Reported | 10.12 | 10.12 | 1.7 | - | - | - | Upgrade
|
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.